ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

June 2, 1995

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

CMS Proposes To End Automatic Coverage Of Clinical Trials For Medicare Patients.

October 12, 2007

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002